MedTrace Logo

Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions

NCT06932289 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2025-04-17

No results posted yet for this study

Summary

It is a 12-week study. The participants will follow three different diets, and during each diet period, and the participants will wear our device, and blood samples will be collected.

Conditions

  • NAFLD (Nonalcoholic Fatty Liver Disease)

Interventions

DIETARY_SUPPLEMENT

Mediterranean diet (MED), high-fat/low carb diet (HF/LC), and low-fat diet (LF)

Participants will be randomized to either Mediterranean diet (MED), high-fat/low carb diet (HF/LC), or low-fat diet (LF).

DEVICE

The integrated sweat sensor and vascular sensor (wearable)

The integrated sweat sensor and vascular sensor will be worn of each diet period.

DEVICE

continuous glucose monitor (CGM)

A continuous glucose monitor (CGM) will be placed on the patients during each diet period.

Sponsors & Collaborators

  • VA Greater Los Angeles Healthcare System

    lead FED

Principal Investigators

  • Tzung Hsiai, M.D., Ph.D. · VAGLAHS and UCLA

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2029-04-30
Completion
2029-05-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06932289 on ClinicalTrials.gov